<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00249951</url>
  </required_header>
  <id_info>
    <org_study_id>FG03-157</org_study_id>
    <nct_id>NCT00249951</nct_id>
  </id_info>
  <brief_title>Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preterm infants are at risk to develop nephrocalcinosis. Incidence numbers vary according to
      birth weight and gestation age. Very low birth weight infants have the highest risk index,
      with ~ 7-10 % of preterm infants developing nephrocalcinosis in the patient population. We,
      the researchers at the University of Cologne, and others found significantly decreased
      urinary citrate excretion (hypocitraturia) to be one of the main risk factors. Hence, we
      hypothesized, that prophylactic treatment with oral alkaline citrate solution (Shol's
      solution) would help to 1) increase urinary citrate excretion and 2) help to decrease the
      incidence of nephrocalcinosis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevention of nephrocalcinosis</measure>
    <time_frame>First eight weeks of life</time_frame>
    <description>Prevention of the development of nephrocalcinosis under prophylactic treatment with an alkaline citrate prepration.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increase in urinary citrate excretion</measure>
    <time_frame>First eight weeks of life</time_frame>
    <description>Increase in urinary citrate excretion under prophylactic treatment</description>
  </secondary_outcome>
  <enrollment type="Actual">80</enrollment>
  <condition>Nephrocalcinosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alkaline citrate</intervention_name>
    <description>Prophylactic alkaline citrate medication during the first 8 weeks of life versus placebo solution to prevent nephrocalcinosis of prematurity.</description>
    <other_name>no brand names, Shol's solution versus placebo solution (NaCl 0.9 %)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm infants &lt; 32 weeks gestation age and &lt; 1500 g birth weight

        Exclusion Criteria:

          -  Cardial, renal or gastrointestinal malformations

          -  Chronic renal failure

          -  Therapy with vitamin B6

          -  High dose treatment with furosemide or dexamethasone

          -  Addison's disease

          -  Severe metabolic alkalosis

          -  Worse clinical condition of preterm infant, which makes oral feeding impossible

          -  Participation in other studies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>8 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernd Hoppe, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Children's Hospital Cologne, Kerpenerstr. 62, D-50924 Cologne, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Prof. Dr. Bernd Hoppe</name>
      <address>
        <city>Cologne</city>
        <zip>D-50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Sikora P, Roth B, Kribs A, Michalk DV, Hesse A, Hoppe B. Hypocitraturia is one of the major risk factors for nephrocalcinosis in very low birth weight (VLBW) infants. Kidney Int. 2003 Jun;63(6):2194-9.</citation>
    <PMID>12753307</PMID>
  </reference>
  <reference>
    <citation>Hoppe B, Duran I, Martin A, Kribs A, Benz-Bohm G, Michalk DV, Roth B. Nephrocalcinosis in preterm infants: a single center experience. Pediatr Nephrol. 2002 Apr;17(4):264-8.</citation>
    <PMID>11956879</PMID>
  </reference>
  <reference>
    <citation>Hoppe B, Roth B, Bauerfeld C, Langman CB. Oxalate, citrate, and sulfate concentration in human milk compared with formula preparations: influence on urinary anion excretion. J Pediatr Gastroenterol Nutr. 1998 Oct;27(4):383-6.</citation>
    <PMID>9779963</PMID>
  </reference>
  <reference>
    <citation>Hoppe B, Hesse A, Neuhaus T, Fanconi S, Forster I, Blau N, Leumann E. Urinary saturation and nephrocalcinosis in preterm infants: effect of parenteral nutrition. Arch Dis Child. 1993 Sep;69(3 Spec No):299-303.</citation>
    <PMID>8215570</PMID>
  </reference>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2005</study_first_submitted>
  <study_first_submitted_qc>November 3, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2005</study_first_posted>
  <last_update_submitted>June 29, 2012</last_update_submitted>
  <last_update_submitted_qc>June 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Prof. Dr. B. Hoppe</investigator_full_name>
    <investigator_title>Head, Division of Pediatric Nephrology</investigator_title>
  </responsible_party>
  <keyword>nephrocalcinosis</keyword>
  <keyword>premature infants</keyword>
  <keyword>hypocitraturia</keyword>
  <keyword>alcaline citrate therapy</keyword>
  <keyword>Nephrocalcinosis in premature infants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nephrocalcinosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

